Press releases
-
-
ICON appoints new Chief Medical Officer
ICON announces the appointment of Dr Kristen Buck as the new Chief Medical Officer (CMO). -
ICON Reports First Quarter 2020 Results
Reported revenue of $715.1 million representing a 6.0% YoY increase or 6.5% on a constant currency basis. Net business wins of $867 million; a book to bill of 1.21. -
ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row
ICON recognised for specialised services offering across product development lifecycle, winning five awards overall. -
ICON signs new Service Agreement with Pfizer
Agreement builds on the companies' existing relationship, under which ICON provides global expertise in the planning, execution, management and conduct of clinical trials. -
ICON launches the Coronavirus Observatory
The Coronavirus Observatory applies powerful AI analysis and data visualisation to COVID-19 news and social media, providing updates on the latest vaccine trials. -
ICON plc to Present at Barclays Global Healthcare Conference 2020
The presentation will be webcast live from 10.15am EDT, Tuesday, March 10, 2020. -
ICON Acquires MedPass International
Acquisition expands ICON’s global Medical Device and Diagnostic Research Services -
ICON Reports Fourth Quarter and Full Year 2019 Results
ICON reports Q4 & 2019 results. Full year reported revenue was $2,806 million. This represents a year on year increase of 8.1% or 9.6% on a constant currency basis -
ICON Issues Financial Guidance for Full Year 2020
Full Year 2020 Revenue guidance in the range of $2,972 - $3,092 million, representing growth of 5.8 – 10.0%.
